BRISTOL-MYERS SQUIBB COMPANY

BMY · NEW YORK STOCK EXCHANGE INC.

Pharmaceutical Preparation Manufacturing

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

ESG Scores

Overall ESG

7.4

Environmental

5.3

Social

4.7

Governance

5.8

Public ESG Grades

Overall: BBB (High)

E: AS: BBG: BB

Gender Diversity

Female Directors0.3333%

CEO GenderMale

Market Data

Price$59.72-0.45 (-0.75%)

Market Cap$122.85B

P/E Ratio17.41

EPS$—

52W High$62.89

52W Low$42.52

Beta0.26